Methotrexate (MTX) works in early PsA. Confirms what we see in clinical practice ◦ Mean disease duration 0.6y ◦ bDMARD naive ◦ MTX monotherapy ➢ ACR20 50.7% ➢ ACR50 30.6% ➢ MDA 22.9% Good to know, our trusted friend MTX works Jose Scher #ReviewCourse @RheumNow #ACR22 https://t.co/ECyM4qtliG